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Abstract
Background: The National Dementia Strategy seeks to enhance general practitioners’ diagnostic and management
skills in dementia. Early diagnosis in dementia within primary care is important as this allows those with dementia
and their family care networks to engage with support services and plan for the future. There is, however,
evidence that dementia remains under-detected and sub-optimally managed in general practice. An earlier
unblinded, cluster randomised controlled study tested the effectiveness of educational interventions in improving
detection rates and management of dementia in primary care. In this original trial, a computer decision support
system and practice-based educational workshops were effective in improving rates of detecting dementia
although not in changing clinical management. The challenge therefore is to find methods of changing clinical
management. Our aim in this new trial is to test a customised educational intervention developed for general
practice, promoting both earlier diagnosis and concordance with management guidelines.
Design/Method: The customised educational intervention combines practice-based workshops and electronic
support material. Its effectiveness will be tested in an unblinded cluster randomised controlled trial with a pre-post
intervention design, with two arms; normal care versus the educational intervention. Twenty primary care practices
have been recruited with the aim of gaining 200 patient participants. We will examine whether the intervention is
effective, pragmatic and feasible within the primary care setting. Our primary outcome measure is an increase in
the proportion of patients with dementia who receive at least two dementia-specific management reviews per
year. We will also examine important secondary outcomes such as practice concordance with management
guidelines and benefits to patients and carers in terms of quality of life and carer strain.
Discussion: The EVIDEM-ED trial builds on the earlier study but the intervention is different in that it is specifically
customised to the educational needs of each practice. If this trial is successful it could have implications for the
implementation of the National Dementia Strategy.
Trial registration: NCT00866099
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Dementia presents many challenges for primary care.
Early diagnosis is important as this allows those with
dementia and their family care networks to engage with
support services and plan for the future. These actions
can relieve the significant psychological distress that
people with dementia and close supporters may experi-
ence [1] and can also provide knowledge about the
availability of medical and psycho-social support that
can improved functioning and morale.
The main efforts to improve the identification and
diagnosis of dementia should logically be targeted at pri-
mary care as this is the first point of contact in the
health service for most individuals and their carers.
There is, however, evidence that dementia remains
under-detected and sub-optimally managed in general
practice [2]. An educational intervention that could
enhance clinical practice, improving the skills of practi-
tioners in the recognition of and response to dementia
syndrome could therefore be beneficial to people with
dementia and their families; in addition it has the poten-
tial to improve the effectiveness of other health and
social services by more timely and appropriate referral.
The National Dementia Strategy [3] seeks to promote
the professional development of general practitioners to
enhance their diagnostic and management skills in
dementia, making this trial particularly timely.
Recognition and response
This project is based on an earlier portfolio of work
which demonstrated that educational interventions can
improve the recognition of dementia syndromes in gen-
eral practice. The Alzheimer’sS o c i e t yD y k e sA w a r d
RCT was an unblinded cluster randomised controlled
study which tested the effectiveness of educational inter-
ventions in improving detection rates and management
of dementia in primary care. A computer decision sup-
port system and practice-based educational workshops
were effective in improving rates of detecting dementia
although not in changing clinical management [4]. One
challenge for the EVIDEM-ED trial is to develop an
intervention that is grounded enough to fit into routine
clinical practice and powerful enough to change the
clinical management of patients with dementia in pri-
mary care.
Changing practice
There are different barriers to changing clinical practice
in different settings and at different times. Change may
be more likely to occur if strategies are chosen to over-
come identified barriers. Barriers can be related to the
individual (e.g. uncertainty about the risks of a proce-
dure); to social issues (e.g. peer pressure to perform a
certain way) and to the organisation of services (e.g. no
access to resources) [5]. Incentives to change also need
to be identified and built into educational strategies [6].
Innovation in practice depends on the attributes of the
new way of working that is being offered [7,8].
The development of an educational intervention needs
to take into account the factors which may influence its
effectiveness. These include personal factors such as
learning styles; external factors such as caseload and
demography of practices; confounding factors such as
other clinical, educational or managerial demands; the
skills of tutors or facilitators; and opportunities for
learning from others [9]. Synthesising these lessons, the
‘ideal’ educational package would allow the practitioner
to build upon existing clinical expertise and knowledge
within a busy and demandingw o r ks c h e d u l e[ 1 0 ]a n d
be flexible enough to accommodate old and new
approaches to education [11]. Above all, such an educa-
tional package needs to be relevant to learners and
enhance their problem-solving capacity by offering
knowledge that can be applied in the normal milieu of
practice as a form of ‘soft technology’,i . e .i nt h et a k e n -
for-granted skills that are brought to bear on routine
clinical tasks [12]. In an evidence-based world, the con-
struction of the ‘ideal’ educational intervention would
require educationalists to work out what needs to be
learned, how that learning can be facilitated and in what
forms knowledge should be organised for maximum
impact on clinical practice.
The necessary and sufficient basis for the development
of an effective educational intervention appears to be
the application of propositional knowledge of the kind
generated by critical appraisal of the research literature
with process knowledge acquired during work with
patients. Two factors are likely to determine the struc-
ture of an educational package in which propositional
knowledge is combined with case discussions. The first
is the distribution of practitioners along a continuum
from novice through advanced beginner, proficient,
competent to expert [13]. The learning process should
allow ‘novices’ to move towards proficiency and so
should contain a hierarchy of complexity in the cases
used to illustrate the application of propositional knowl-
edge. However, since general practices contain doctors
and nurses with different levels of experience and differ-
ent agendas when approaching patient care, it must also
allow the competent and proficient to expand their
repertoire of skills without working on material that is
already within their abilities. The advantage of learning
in a mixed ability and mixed professional group is that
peers and colleagues can be the most effective educators
[14] and there is a particular benefit from learning from
other disciplines [15].
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to develop a flexible learning needs assessment tool that
allows an educational intervention to be tailored to
practice needs and the skills of the existing practice
team. Further details of how this tailored intervention
was developed are available elsewhere [16,17]. This
intervention will be tested in the EVIDEM-ED rando-
mised controlled trial.
Aims and Objectives
Our aim is to develop and test an educational interven-
tion for general practice, combining timely diagnosis
and psychosocial support around the period of diagnosis
with concordance with management guidelines [2,3].
The objectives of the study are:
1. To develop an educational intervention suitable for
workplace use that has the potential to change manage-
ment practice in dementia care amongst general practi-
tioners and practice nurses.
2. As part of management in general practice, to
include shared care guidelines for medication use by
patients with dementia.
3. Developing and testing electronic resources that
promote the above objectives.
Design
Trial design
The effectiveness of an educational intervention combin-
ing practice-based workshops and computer based sup-
port will be tested in a pragmatic unblinded cluster
randomised controlled trial with a pre-post design and
with two arms; normal care versus educational interven-
tion (see consort diagram in Figure 1). The researchers
will be aware of group allocation but carers and people
with dementia will not be informed.
Study setting
The study will take place within Primary care practices
in the geographical care covered by the North Thames
Dementias and Neurodegenerative Diseases Research
Network (NT DeNDRoN); Metropolitan North London,
Essex, Hertfordshire and Bedfordshire. Approval for the
trial has been received from Southampton & South west
Hampshire Research ethics Committee (A): reference
09/H0502/77
Educational intervention
The educational intervention consists of practice based
workshops with a tailored curriculum designed by a
multidisciplinary expert group and supplemented by
electronic resources. The educational interventions
reflect different approachesto adult learning, namely
workshops directly relevant to clinical practice, allowing
learning to occur through peer reflection about real
cases, and electronic resource materials suitable for ‘real
time’ use in consultations.
Workshops
The EVIDEM programme has developed a workplace-
based approach to training GPs in dementia diagnosis
and management. The essential components of this
approach are an ‘educational needs assessment’ and an
‘educational prescription’. The educational needs
assessment requires a one hour group meeting in the
workplace, with the membership of the group deter-
mined by the work unit - in our case, the general prac-
tice. The facilitator of the group uses a standard
checklist to elicit the strengths and weaknesses of the
organisation’s current practice with people with
dementia (see Figure 2). Because inexperienced profes-
sionals often misjudge their learning needs, silences
and absences in this discussion are interpreted by the
facilitator. For example, it is possible for a general
practice to discuss dementia care for most of the hour
without mentioning carers’ needs; the facilitator must
point this out. The group can then identify the highest
priority topics for learning and decide how it wishes
those topics to be presented - as workshops, in an
electronic format for self-directed learning, or with a
printed manual (Appendix 1).
Recruitment
Primary Care practices
Interested general practices in the North Thames DeN-
DRoN area will be identified in collaboration with the
local Primary Care Research Networks: the Primary
Care Research Network-Greater London (PCRN-GL)
and the Primary Care Research Network-East of Eng-
land (PCRN-EoE). Practices will be contacted by the
Trial research team, by letter and awareness-raising
through general practice educational meetings and by
regular newsletters.
Inclusion criteria
The inclusion criteria for practices in this study will be:
1) routine data collection from clinical encounters on
electronic medical records and; 2) team commitment to
participate in educational workshops held in the prac-
t i c e .( A l ls t a f fw o r k i n gi nt h ep r a c t i c ew i l lb ee l i g i b l et o
participate in the study.)
Exclusion criteria
Practices that do not routinely capture clinical data in
electronic records will be excluded.
Patients with dementia and their carers
Inclusion criteria
The inclusion criteria for people with dementia in this
study will be a diagnosis or suspected diagnosis of
dementia of any type, with no lower age limit.
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Exclusion criteria will be: 1) people who cannot speak
English and for whom an interpreter cannot be located;
2) if the patient or carer are involved in concurrent
research; 3) if the key professional feels that an
approach to the person with dementia or their carer
would be inappropriate where, for example, the demen-
tia is very severe or that an approach may increase dis-
tress and; 4) any other important reason that the key
professional may have for why the person with dementia
or their carer should not be contacted.
Every effort will be made to include those who meet
the inclusion criteria but may not adequately understand
verbal explanations or written information given in Eng-
lish. Where applicable, an independent and qualified
translator/interpreter will be sought and invited to assist.
Outcome measurements
Primary outcome
We derived our primary outcome measure and the
effect size from discussions with practitioners in the fea-
sibility phase of the trial. The consensus was that the
Recruit practices and 
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Figure 1 The Consort EVIDEM-ED-Flowchart.
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required at least two encounters per year, and that the
educational intervention would promote this effectively
in a majority of those in the intervention arm. Our
hypothesis is, therefore, that in the intervention arm, the
proportion of patients receiving two dementia-specific
management reviews per year will increase between
groups of patients by 50%, i.e. 20% (control) versus 70%
(intervention), after the introduction of the educational
intervention. Data relating to dementia-specific patient
reviews and consultations relevant to dementia manage-
ment will be extracted from the practice records.
Secondary outcome
1) Concordance with guidelines.
We will transcribe and scrutinise manual and electro-
nic records for the recording of actions considered to be
best practice in the diagnosis and management of
dementia in primary care by using the NICE/SCIE
dementia guidelines [2]. Appendix 1 shows the compo-
nents of good practice that will be captured. The index
consultation is the one where the suspicion of possible
dementia is first recorded (Appendix 2).
2) Measurement of unmet needs in patients and
carers.
Figure 2 The identification of participants and how these will be approached, recruited and consented/consulted about EVIDEM: ED.
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developed and validated by us in a previous trial [18].
Sample size
Based on the study having 90% power to detect as sig-
nificant, using a 5% 2-tailed significance level, a differ-
ence in the proportion of individuals with 2 or more
dementia related GP visits of 50% (control: 20% versus
Intervention: 70%) the required sample size, based on
individual randomisation would be 23 per group - a
total of 46 individuals. However, due to the use of clus-
ter randomisation, the total required sample size needs
to be inflated in order to take account of this clustering.
The number of patients recruited per practice will also
need to be inflated in order to maintain the sample
sizes in the presence of attrition [19,20]. With 20 prac-
tices (10 per arm), the power to detect the differences
postulated would be maintained if the ICC were of the
o r d e r0 . 3 7o rl e s s .T h u st h ee f f e c t i v es a m p l es i z ew i t h
10 patients per cluster and 20 practices would need to
be 200. If the expected attrition rate were 1/3 (33.3%)
then 15 patients would need to be recruited per practice
in order to maintain the sample size of 10 patients per
practice.
Procedure
All practices will be asked to identify patients with
symptoms of dementia by using electronic searches of
their clinical record system updated by manual checks
of the resulting list by medical and nursing staff. Where
there is no informal carer eligible for interview, advice
regarding consent for examination of medical records
will be sought from an appropriate consultee. No perso-
nalised information will be retained following the record
examinations, which will be carried out in the surgery
by research team members who have honorary contracts
with the relevant PCT.
This trial will last 36 months allowing for a follow-up
period of 12 months that will capture effects on clinical
practice, carer satisfaction, met and unmet needs. Data
will be gathered before and 12 months after the intro-
duction of the educational interventions.
Intervention
Participating practices will be randomised by an inde-
pendent person to intervention or control arms using a
computer generated randomisation programme. Prac-
tices randomly allocated to the intervention arm will be
asked to participate in tailored learning activities con-
sisting of an educational needs assessment followed by
up to three face-to-face educational workshop sessions
on dementia over a three-month period and will be
given electronic resources which they can use during
and after consultations with people with known or sus-
pected dementia syndrome. Each educational workshop
will be arranged at dates/times convenient to the prac-
tice team.
An experienced general practitioner with a back-
ground in postgraduateeducation will facilitate the small
group workshops with the practice team. Tailoring of
the education programme is carried out in a three step
process: 1) in the first workshop, an educational needs
analysis is undertaken using a standard checklist to
identify aspects of dementia care which the practice per-
ceives as problematic for them; 2) a prescription to
meet the practice team’s educational needs is then writ-
ten to address shortcomings and sorting out the appro-
priate written educational resources, and; 3) the best
forms of learning are then identified with a delivery and
discussion with the team of the selected educational
resource materials in the light of their perceived needs.
The ‘normal care’ arm will be given a summary of the
NICE/SCIE dementia guidelines [2] and offered work-
shop training and electronic tools and resources at the
end of the study. General practitioners, practice nurses
and any other staff involved will be invited to give feed-
back on the educational resources.
Practices will be offered financial reimbursement to
cover the use of locums and data collection costs (e.g.
recruitment of patients and carers). Payments will be
based on a sliding scale according to the number of
partners in the practice, up to a maximum allocation.
Consent
People with dementia will be identified by practices and
their lead clinician will check whether they fulfil the
inclusion criteria. Where the lead clinician believes that
the individual should not be approached (e.g. because
they are receiving palliative care) they will be excluded.
Before seeking consent from patients to participate in
the study, practitioners will be asked for their opinion
about the capacity of the person with dementia to give
informed consent, using the Mental Capacity Act [21]
as the framework for their judgement.
For patients judged as having capacity, the following
information will be posted to the person with dementia:
1) a covering letter explaining the involvement of the
practice and signed by the lead clinician; 2) a participant
information sheet and; 3) a response letter and pre paid
envelope to be returned to the research team. A
researcher will arrange to see those patients with
dementia and their carers who express an interest in
participating in the study. This encounter can take place
at the patient’s home or in the practice, as they wish. Its
purpose is to seek consent from the carer and consent/
assent from the person with dementia for their partici-
pation in the study and allowing access to patient
records.
For those judged by the lead clinician as lacking capa-
city to give informed consent, a consultee as outlined in
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sulted about possible involvement of the person with
dementia in the trial. The relevant clinician will write to
the consultee providing full information about the trial
and asking whether or not they consent on behalf of the
patient to enrolment.
Every effort will be made to identify a consultee for
those judged to lack capacity to give informed consent.
In the event that a consultee cannot be identified, the
person with dementia will be excluded from participa-
tion in the trial. Figure 2 shows the process of identify-
ing participants and how these will be approached,
recruited and consented/consulted about EVIDEM-ED.
The process for obtaining participant informed con-
sent or assent and guardian informed consent will be in
accordance with the REC guidance [22], the Mental
Capacity Act [21] and Good Clinical Practice (GCP)
[23]. The investigator or their nominee and the partici-
pant or other legally authorised representative shall both
sign and date the Informed Consent Form before the
person can participate in the study. The participant will
receive a copy of the signed and dated forms and the
original will be retained in the Trial Master File. A third
copy will be filed in the participant’s medical notes and
as i g n e da n dd a t e dn o t em a d ei nt h en o t e st h a t
informed consent was obtained for the trial.
With the informed consent of the person with demen-
tia or their consultee, members of the research team
will examine medical records in the surgery, using the
themes shown in Appendix 1 to guide data extraction.
No personalised information will be recorded or
retained by the researcher and each case will be allo-
cated a unique study number for the purposes of
recording data. All other information will be stored in
accordance with the Data Protection Act.
Statistical analyses
We will assess the effect of the interventions at the
practice level because the data will be cluster based and
analyses will be performed on an intention to treat
basis. Analyses of all quantitative responses will be per-
formed with a general linear model with the arm and
time as fixed effects and practice identity as a random
effect.
We will analyse differences in detection rates by using
binary logistic regression to include the cluster effect.
These will be calculated before and after the interven-
tion, excluding cases previously diagnosed in another
practice. Concordance scores for diagnosis and manage-
ment before and after the intervention will not directly
be comparable as they comprise counts of actions taken
over two different lengths of time. We will use Vickers’
method and examine differences in baseline concor-
dance scores across the arms of the study and then
repeat the analysis for scores after the intervention. This
analysis will also incorporate the cluster effect.
If outcome data are missing, we will assume they are
“missing at random” (MAR). This means that the prob-
ability of missing data can be predicted by variables
measured at baseline. In this case, an analysis which
adjusts for the baseline predictors of ‘missingness’ (at
least baseline response and treatment) will give an
unbiased estimated of the treatment effect, making mul-
tiple imputation unnecessary. Multiple imputation will
be used only if important baseline predictors are miss-
ing. Methods will then be employed which take account
of the clustered nature of the data
Trial management
T h et r i a lw i l lb el e db yt h eP r i n cipal Investigator, Prof.
Steve Iliffe and managed by the Programme Manager
Ms. Jane Wilcock. The trial co-ordinating centre is the
Department of Primary Care and Population Health at
University College London. A Trial Management Com-
mittee will meet every two months to review the pro-
gress of the trial and its members will be recruited
from; 1) the research teams in the EVIDEM programme
and; 2) patient and public representatives working with
the EVIDEM programme. A Trial Steering Committee
(TSC) with a majority of members independent of the
EVIDEM programme will meet six monthly to review
the study. Because there were no adverse outcomes in
the earlier trial of educational interventions, we propose
not to have a data management committee but to give
the chair of the TSC powers to convene a data manage-
ment sub-group should there be any need to consider
adverse events.
Stopping rules and discontinuation
Participants can chose to leave the trial at any point.
The trial will be terminated if it is shown to have a
negative impact on routine medical care.
Duration of the trial
The Trial will run for 36 months depending on the
speed of recruitment of practices. Practices randomly
allocated to receive training will receive this within
three months period, with data collection at baseline
and again at 12 months following baseline assessment.
Participant involvement
Practices will receive regular updates on the trial’sp r o -
gress via newsletters and other media and will also be
invited to annual summer schools and seminars run by
the EVIDEM programme. This will include receiving
study findings at the end of the Trial. Practices allocated
to the control arm will receive training after the data
collection period. The people with dementia and carers
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version of the study outcomes and be invited to a lay
conference at the end of the study period.
User and public involvement
All user and carer representatives from the NICE/SCIE
guideline development group have agreed to join the
Reference Group that meets annually to provide critical
evaluation of the EVIDEM programme by which the
EVIDEM-ED study is overseen. They will bring their
experience of the guideline development process and in
particular their awareness of the specific gaps in evi-
dence and the methodological problems of dementia
research in the community. Members of the Reference
group also include representatives from the Alzheimer’s
Society, the Council for Palliative Care, Age Concern
England, the Association of London Government,
Dementias and Neurodegenerative Diseases Research
Network (DeNDRoN), national co-ordinating centre and
the Mental Health Trust.
Adverse events
We do not anticipate any unfavourable and unintended
signs, symptoms, syndromes or illness to be caused to
patients by general practitioners’ participation in the
trial. However, it is possiblet h a ta nu n k n o w ns e r i o u s
condition, treatment or behaviour could come to the
attention of the researchers.
Participants will be asked to contact the study site
immediately in the event of any serious adverse event.
All adverse events will be recorded and closely moni-
tored until resolution or stabilisation, or until it has
been shown that the study involvement is not the cause.
The Chief Investigator shall be informed immediately of
any serious adverse events and shall determine serious-
ness and causality in conjunction with any unexpected
outcome of trial participation, together with the chair of
the TSC.
In the event of a hitherto unknown severe or serious
condition or situation becoming apparent to the
research team, this will be discussed with the Chief
Investigator who will notify the appropriate service as
required. The Chief Investigator shall be responsible for
all adverse event reporting. Any participant who experi-
ences an adverse event may be withdrawn from the
study at the discretion of the Investigator, but in consul-
tation with the patient, their carer (where appropriate)
and their general practitioner.
Ethical issues
This study has particular ethical implications. Gaining
consent from people with dementia raises complex
issues and full research governance processes will be fol-
lowed to gain meaningful informed consent, or where
necessary, consult with those who are able to act as
decision-makers. We have obtained ethical permissions
from the NHS ethical review system and relevant NHS
governance departments. We shall follow local adult
protection procedures in each of the localities of the
research and data collection.
Ethics committee and regulatory approvals
The trial will not be initiated before the protocol,
informed consent forms and participant and GP infor-
mation sheets have received approval/favourable opinion
from the Research Ethics Committee (REC) and the
respective National Health Service (NHS) Research and
Development (R&D) department. Should a protocol
amendment be made that requires REC approval, the
changes in the protocol will not be instituted until the
amendment and revised informed consent forms and
participant and GP information sheets (if appropriate)
have been reviewed and received approval/favourable
opinion from the REC and R&D departments. A proto-
col amendment intended to eliminate an apparent
immediate hazard to participants may be implemented
immediately providing that the REC are notified as soon
as possible and an approval is requested. Minor protocol
amendments only for logistical or administrative
changes may be implemented immediately and the REC
will be informed.
Discussion
The EVIDEM-ED trial progresses from an earlier study
and is developing and testing an intervention that is
customised to the educational needs of individual prac-
tices. The deliverables from this programme will include
an educational intervention for general practice and
practice nursing combining timely dementia diagnosis
and psychosocial support around the period of diagnosis
with components appropriate to later stages of the dis-
ease trajectory. It will also include electronic resources
o nt h es a m et h e m e st o g e t h e rw i t hs h a r e dc a r eg u i d e -
lines for medication use. All deliverables will be made
freely available to the NHS within the timeframe of the
study.
The limitations that we anticipate are that the study is
taking place in the South East of England, that partici-
pant practices will be more likely to be innovative early
adopters than typical of general practice, and that local
educational programmes developed to implement the
National Dementia Strategy may influence practice
activities. However, the results of this study may have
wider implications, particularly about the value of tailor-
ing educational interventions. The findings may be
widely applicable to general practice and, if the trial
shows benefit, could be utilised nationally within
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National Dementia Strategy [3].
Appendix 1
Semi-structured checklist to guide discussion in the
educational needs assessment.
Questions
1. How would you rate your current care for people
with dementia and their carers (using a simple scale
of good enough/satisfactory/needs substantial
improvement)?
2. What grounds or criteria is your rating based on?
3. Does the number of people in your practice diag-
nosed with dementia correlate with the local preva-
lence figures?
4. How do you arrive at your decision for diagnosis
of dementia?
5. How many older people with suspected dementia
did you refer last year?
6. After diagnosis, what follow-up do you provide to
people with dementia and their carers?
7. Are you using a shared care protocol for cholines-
terase inhibitors? If ‘yes’, then: (i) who was involved
in producing the protocol; (ii) who is involved in it
implementation (e.g. hospital consultants, CPNs,
Care of Older People team)
8. How effective do you think cholinesterase inhibi-
tors are and how effective have you found them in
your practice?
9. What non-pharmacological alternatives do you
have available to help your patients (and their carers)
10. Based on your experience, what do you think are
the important quality markers in caring for people
with dementia? (What would you want for yourself?)
11. Is there anything that you would like improve
about your current practice with patients with
dementia? If yes, what is it and why would you like
it to change?
Appendix 2
Secondary outcome indicators; components of good
practice.
Diagnosis concordance
1. Request for blood tests at or after index consultation
but before formal diagnosis
2. History of patient’ss y m p t o m sd o c u m e n t e da to r
after index consultation but before formal diagnosis
3. Cognitive testing at or after index consultation but
before formal diagnosis
4. Depression screen used at or after index consulta-
tion but before formal diagnosis
5. Possible diagnosis discussed with patient or carer,
or both
6. Referral to specialist service (including memory
assessment unit) at or after index consultation
Management concordance
1. Concerns of carer explored and documented
2. Behavioural and psychological symptoms elicited
3. Depression assessment or treatment documented
4. Referral to, or involvement of, social services
5. Referral to, or involvement of, voluntary
organisations
6. Cholinesterase inhibitor drugs considered
7. Review of medication documented.
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